Pharmaceutical Industry
Page 18 of 100
NewslettersEli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
By Sheryl EstradaNovember 29, 2023
LeadershipHow the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines
By Christiaan HetznerNovember 27, 2023
FinanceBiden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By Arthur Allen and KFF Health NewsNovember 16, 2023
CommentaryOur changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By Martine Ferland and Judy MonroeNovember 15, 2023
By Ryan HoggNovember 6, 2023
MindJust 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
By Erin PraterNovember 3, 2023
HealthNovo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By Prarthana PrakashNovember 3, 2023
By Sheryl EstradaNovember 3, 2023
NewslettersCEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business
By Jessica MathewsOctober 31, 2023
By The Associated PressOctober 30, 2023
HealthU.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By Christiaan HetznerOctober 28, 2023
CommentaryClimate change is our greatest health crisis. The same investments can often address both threats
By Vanessa Kerry and Paul HudsonOctober 19, 2023
HealthWhy a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023
Most Popular
